Could a higher metformin dose help young people with diabetes?

NCT ID NCT06120881

Recruiting now Disease control Sponsor: University of California, San Francisco Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares the usual dose of metformin (1000 mg twice a day) with a higher dose (1350 mg twice a day) in 20 youth aged 10-21 with type 2 diabetes. The goal is to see if the higher dose is acceptable and feasible, and whether it improves blood sugar control. Participants will wear a continuous glucose monitor for 6 weeks to track their glucose levels.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 2 DIABETES

Contacts and locations

Locations

UCSF Benioff Children's Hospital Oakland, Pediatric Diabetes Clinic
RECRUITING

Oakland, California, 94609, United States
UCSF Benioff Children's Hospital San Francisco, Madison Clinic for Pediatric Diabetes
RECRUITING

San Francisco, California, 94158, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.